Obr Peer-spectives
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 3:20:10
- Mas informaciones
Informações:
Sinopsis
News, Perspective, Catalyst
Episodios
-
CAR-T and Lymphoma – Michael Jain, MD, and Robert Figlin, MD, discuss the role of CAR-T in the treatment of lymphoma
26/03/2020Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Michael Jain, MD, Assistant Member, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, discuss the role of CAR-T and the treatment of lymphoma and off-the-shelf CAR-T
-
Prostate Cancer – Daniel Petrylak, MD, and Robert Figlin, MD, discuss recent clinical advances in prostate cancer from ASCO GU
02/03/2020Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Daniel Petrylak, MD, Professor of Medicine, Medical Oncology and Urology, Co-Leader, Cancer Signaling Networks, Yale Cancer Center, discuss the progress in prostate cancer presented at ASCO GU ’20
-
Colorectal Cancer – Zev Wainberg MD, and Robert Figlin, MD, discuss recent clinical advances in colorectal cancer from ASCO GI
18/02/2020Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Zev Wainberg, MD, Assistant Professor of Medicine at UCLA and Co-Director of the UCLA GI Oncology Program, discuss the progress in colorectal cancer presented at ASCO GI ’20
-
Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, provide post ESMO ’19 clinical update
17/01/2020Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Bradley Monk, MD, FACOG, FACS, Professor and Director of the Division of Gynecologic Oncology at Creighton University School of Medicine, discuss ovarian cancer clinical updates from ESMO 19
-
Colorectal Cancer – Marwan Fakih, MD, and Robert Figlin, MD, provide post ESMO ’19 clinical update
17/01/2020Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Marwan Fakih, MD, Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, discuss colorectal cancer clinical updates from ESMO 19
-
Lung Cancer – Geoffrey Oxnard, MD, and Robert Figlin, MD, discuss integrating liquid biopsies into lung cancer care
17/01/2020Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Geoffry R. Oxnard, MD, Associate Professor of Medicine, Associate Professor of Medicine, Dana Farber Cancer Instituate, Harvard Medical School, discuss integrating liquid biopsies into lung cancer care
-
Acute Myeloid Leukemia (AML) – Courtney DiNardo MD, and Robert Figlin, MD, discuss the latest clinical developments in AML
10/01/2020Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Courtney DiNardo, MD Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discuss the latest clinical developments in AML
-
Gastric/GE Junction Cancer – Howard Hochster, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO 2019
16/12/2019Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Howard Hochster, MD, Professor of Medicine Associate Director for Clinical Research and Director, GI Oncology, Rutgers Cancer Institute, discuss gastric/GE junction cancer clinical highlights from ASCO 2019.
-
Pancreatic Cancer – Vincent Chung, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO 2019
16/12/2019Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Vincent Chung, MD, Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, discuss pancreatic cancer highlights from ASCO 2019.
-
Breast Cancer – Neelima Denduluri, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO 2019
16/12/2019Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Neelima Denduluri, MD, Medical Oncologist, Virgina Cancer Specialists, discuss breast cancer highlights from ASCO 2019.
-
Colorectal Cancer (CRC) – Scott Kopetz, MD, and Robert Figlin, MD, provide post World GI ’19 clinical update
06/08/2019 Duración: 12minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Scott Kopetz, MD, PhD, FACP, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, MD Anderson, provide CRC clinical update post World GI ’19.
-
Hepatocellular carcinoma (HCC) – Daneng Li, MD and Robert Figlin, MD, discuss clinical highlights from ASCO 2019
03/07/2019 Duración: 14minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Daneng Li, MD, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, discuss HCC highlights from ASCO 2019.
-
Lung Cancer – Edward Garon, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO 2019
03/07/2019 Duración: 14minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Edward Garon, MD, Associate Professor of Medicine, Geffen School of Medicine at UCLA, discuss lung cancer highlights from ASCO 2019.
-
Urothelial Cancer – Bradley McGregor, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO 2019
03/07/2019 Duración: 13minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Bradley McGregor, MD, Clinical Director, Lank Center for Genitourinary Oncology, Professor of Medicine, Harvard Medical School, discuss urothelial cancer clinical highlights from ASCO 2019.
-
Keytruda RCC Approval/I-O – Toni Choueiri, MD, and Robert Figlin, MD, discuss the recent Keytruda approval in renal cell carcinoma (RCC)
03/07/2019 Duración: 13minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Toni Choueiri, MD, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, discuss Keytruda’s approval in renal cell carcinoma (RCC).
-
Renal Cell Carcinoma (RCC) – Rana McKay, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO GU 2019
05/03/2019 Duración: 14minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Rana McKay, Assistant Professor of Medicine, University of California San Diego, discuss renal cell carcinoma (RCC) clinical highlights from ASCO GU 2019
-
Colorectal Cancer (CRC) – Axel Grothey, MD, and Robert Figlin, MD, provide clinical update in CRC
05/03/2019 Duración: 14minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Axel Grothey, MD, Director of GI Research, West Cancer Center, University of Tennessee, discuss new data from the BEACON study and the role of I-O and HIPEC in colorectal cancer
-
Hepatocellular Carcinoma (HCC) – Richard Finn, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019
13/02/2019 Duración: 15minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Richard Finn, MD, Professor of Medicine at the Geffen School of Medicine, UCLA, discuss hepatocellular carcinoma (HCC) clinical highlights from ASCO GI 2019
-
Biliary Tract and GE Junction Cancers – Tanios Bekaii-Saab, MD, FACP, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019
08/02/2019 Duración: 13minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Tanios Bekaii-Saab, MD, Professor, Mayo Clinic College of Medicine and Science, discuss biliary tract and GE junction cancer clinical highlights from ASCO GI 2019
-
CAR-T Cell Therapy – Frederick Locke, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018
18/12/2018 Duración: 09minRobert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Frederick Locke, MD, Program Co-Leader, Immunology, Moffitt Cancer Center discuss CAR-T clinical highlights from ASH 2018